Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study

被引：0
|
作者：
Tan, A. H. [1 ]
Lim, S. Y. [1 ]
Mahadeva, S. [1 ]
Loke, M. F. [1 ]
Vadivelu, J. S. [1 ]
Marras, C. [1 ]
Fox, H. [1 ]
Lang, A. E. [1 ]
机构：
[1] Univ Malaya, Kuala Lumpur, Malaysia
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
954
引用
收藏
页码：S422 / S425
页数：4
相关论文
共 50 条
  • [41] Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients
    Bonfigli, A. R.
    Boemi, M.
    Festa, R.
    Bonazzi, P.
    Brandoni, G.
    Spazzafumo, L.
    Olivieri, F.
    Ceriello, A.
    Genovese, S.
    Testa, R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (10) : 893 - 898
  • [42] Evaluation of efficacy and safety of Lacticaseibacillus rhamnosus LRa05 in the eradication of Helicobacter pylori: a randomized, double-blind, placebo-controlled trial
    Niu, Yue
    Li, Jing
    Qian, Hongwei
    Liang, Chunli
    Shi, Xinyi
    Bu, Shurui
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Randomized, double-blind, placebo-controlled multicenter study to assess the effect of Helicobacter pylori (HP) eradication in patients with gastro-esophageal reflux disease (GERD):: the erastrat study
    Schwizer, Werner
    Menne, Dieter
    Fried, Michael
    Schuetze, Kurt
    Fox, Mark R.
    GASTROENTEROLOGY, 2008, 134 (04) : A175 - A175
  • [44] Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease
    Suzuki, Masahiko
    Yoshioka, Masayuki
    Hashimoto, Masaya
    Murakami, Maiko
    Noya, Miki
    Takahashi, Daisuke
    Urashima, Mitsuyoshi
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (05): : 1004 - 1013
  • [45] Zishenpingchan granules for the treatment of Parkinson's disease:a randomized,double-blind,placebo-controlled clinical trial
    Qing Ye
    Xiao-Lei Yuan
    Can-Xing Yuan
    Hong-Zhi Zhang
    Xu-Ming Yang
    Neural Regeneration Research, 2018, (07) : 1269 - 1275
  • [46] Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial
    Ye, Qing
    Yuan, Xiao-Lei
    Yuan, Can-Xing
    Zhang, Hong-Zhi
    Yang, Xu-Ming
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1269 - 1275
  • [47] Pingchan granule for depressive symptoms in parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Gu, Si-chun
    Zhou, Jie
    Ye, Qing
    Yuan, Can-xing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2021, 19 (02): : 120 - 128
  • [48] Pingchan granule for depressive symptoms in parkinson's disease:A randomized, double-blind, placebo-controlled trial
    Si-chun Gu
    Jie Zhou
    Qing Ye
    Can-xing Yuan
    Journal of Integrative Medicine, 2021, 19 (02) : 120 - 128
  • [49] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [50] Clozapine improves dyskinesias in Parkinson disease - A double-blind, placebo-controlled study
    Durif, F
    Debilly, B
    Galitzky, M
    Morand, D
    Viallet, F
    Borg, M
    Thobois, S
    Broussolle, E
    Rascol, O
    NEUROLOGY, 2004, 62 (03) : 381 - 388
12345